ACTG 300 leaves many questions unanswered
Gilden, D.
Gmhc Treatment Issues the Gay Men's Health Crisis Newsletter of Experimental Aids Therapies 11(7-8): 35-36
1997
ISSN/ISBN: 1077-1824 PMID: 11364654 Document Number: 470079
The pediatric trial ACTG 300 was closed early when the data collected showed that AZT/3TC and AZT/ddI combinations were both superior to monotherapy for treating children with HIV. The original test was designed to compare differences in clinical progression in children using combination therapies, and the trial has been hailed as proving that more drugs are effective than one. A table includes data on the trial results.